Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
10.47
+0.22 (2.15%)
At close: May 12, 2025, 4:00 PM
10.47
0.00 (0.00%)
After-hours: May 12, 2025, 4:02 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $382.13 million as of May 12, 2025.
Market Cap
382.13M
Enterprise Value
104.59M
1-Year Change
n/a
Ranking
Category
Stock Price
10.47
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $382.13M, a decrease of -36.46%. That is a compound annual growth rate of -38.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 374.10M | -42.35% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |